Abstract
About 90% of sequence variants in humans are differences in single bases of DNA, called single nucleotide polymorphisms (SNPs). When two individuals are compared, their genomic DNA differs at ∼1/1000 nucleotides (1). Neutral polymorphisms may be responsible for subtle differences between individuals, such as hair and eye color, or may be silent identifiers of variability and relatedness. Other polymorphisms cause genetic diseases such as hemophilia and are referred to as mutations. Polymorphisms within an individual may cause cancer or other diseases, are responsible for the variability of our immune response, and have been implicated in the aging process. Identification of polymorphisms can therefore be useful in diagnosis of genetic disease, detection of tumors, study of immune response and aging, identification of microbial strains, and developing relatedness trees between humans or other organisms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kwok P. Y., Deng Q., Zakeri H., Taylor S. L., and Nickerson D. A. (1996) Increasing the information content of STS-based genome maps: identifying polymorphisms in mapped STSs. Genomics 31, 123–126.
Kwok S., Kellogg D. E., McKinney N., Spasic D., Goda L., Levenson C., and Sninsky J. J. (1990) Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res. 18, 999–1005.
Ørum H., Nielsen P. E., Egholm M., Berg R. H., Buchardt O., and Stanley C. (1993) Single base pair mutation analysis by PNA directed PCR clamping. Nucleic Acids Res. 21, 5332–5336.
Kyger E. M., Krevolin M. D., and Powell M. J. (1998) Detection of the hereditary hemochromatosis gene mutation by real-time fluorescence polymerase chain reaction and peptide nucleic acid clamping. Anal. Biochem. 260, 142–148.
Murdock D. G., Christacos N. C., and Wallace D. C. (2000) The agerelated accumulation of a mitochondrial DNA control region mutation in muscle, but not brain, detected by a sensitive PNA-directed PCR clamping based method. Nucleic Acids Res. 28, 4350–4355.
Behn M. and Schuermann M. (1998) Simple and reliable factor V genotyping by PNA-mediated PCR clamping. Thromb. Haemost. 79, 773–777.
Thiede C., Bayerdorffer E., Blasczyk R., Wittig B., and Neubauer A. (1996) Simple and sensitive detection of mutations in the ras protooncogenes using PNA-mediated PCR clamping. Nucleic Acids Res. 24, 983–984.
Behn M., Thiede C., Neubauer A., Pankow W., and Schuermann M. (2000) Facilitated detection of oncogene mutations from exfoliated tissue material by a PNA-mediated ‘enriched PCR’ protocol. J. Pathol. 190, 69–75.
Rhodes C. H., Honsinger C., Porter D. M., and Sorenson G. D. (1997) Analysis of the allele-specific PCR method for the detection of neoplastic disease. Diagn. Mol. Pathol. 6, 49–57.
Myal Y., Blanchard A., Watson P., Corrin M., Shiu R., and Iwasiow B. (2000) Detection of genetic point mutations by peptide nucleic acid-mediated polymerase chain reaction clamping using paraffin-embedded specimens. Anal. Biochem. 285, 169–172.
Bianco P., Riminucci M., Majolagbe A., Kuznetsov S. A., Collins M. T., Mankani M. H., et al. (2000) Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J. Bone Min. Res. 15, 120–128.
Zhong S., Nguyen N. Y., and Eggerman T. L. (1999) Detection of apolipoprotein B mRNA editing by peptide nucleic acid mediated PCR clamping. Biochem. Biophys. Res. Comm. 259, 311–313.
vonWintzingerode F., Landt O., Ehrlich A., and Gobel U. B. (2000) Peptide nucleic acid-mediated PCR clamping as a useful supplement in the determination of microbial diversity. Appl. Environ. Microbiol. 66, 549–557.
Feder J. N., Tsuchihashi Z., Irrinki A., Lee V. K., Mapa F. A., Morikang, E., et al. (1997) The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J. Biol. Chem. 272, 14,025–14,028.
Takahashi S., Chi X. J., Yamaguchi Y., Suzuki H., Sugaya S., Kita K., et al. (2001) Mutagenicity of bisphenol A and its suppression by interferon-alpha in human RSa cells. Mutat. Res. 490, 199–207.
Behn M. and Schuermann M. (1998) Sensitive detection of p53 gene mutations by a ‘mutant enriched’ PCR-SSCP technique. Nucleic Acids Res. 26, 1356–1358.
Cochet O., Martin E., Fridman W. H., and Teillaud J. L. (1999) Selective PCR amplification of functional immunoglobulin light chain from hybridoma containing the aberrant MOPC 21-derived V kappa by PNA-mediated PCR clamping. Biotechniques 26, 818–820, 822.
Mrozikiewicz P. M., Landt O., Cascorbi I., and Roots I. (1997) Peptide nucleic acid-mediated polymerase chain reaction clamping allows allelic allocation of CYP1A1 mutations. Anal. Biochem. 250, 256–257.
Aynacioglu A. S., Cascorbi I., Mrozikiewicz P. M., and Roots I. (1998) High frequency of CYP1A1 mutations in a Turkish population. Arch. Toxicol. 72, 215–218.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc.
About this protocol
Cite this protocol
Murdock, D.G., Wallace, D.C. (2002). PNA-Mediated PCR Clamping. In: Nielsen, P.E. (eds) Peptide Nucleic Acids. Methods in Molecular Biology, vol 208. Springer, Totowa, NJ. https://doi.org/10.1385/1-59259-290-2:145
Download citation
DOI: https://doi.org/10.1385/1-59259-290-2:145
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-0-89603-976-6
Online ISBN: 978-1-59259-290-6
eBook Packages: Springer Protocols